Two New Cosmetic Ingredients, Including Hydroxyethyl Imidazolidinone, Added to the Inventory of Existing Cosmetic Ingredients
On November 17, in accordance with the Announcement of the National Medical Products Administration on Matters Concerning the Administration of the Inventory of Existing Cosmetic Ingredients, the National Medical Products Administration (NMPA) conducted the sixth dynamic update of the Inventory of Existing Cosmetic Ingredients.
Two new cosmetic ingredients, Hydroxyethyl Imidazolidinone and CHENO PODIUM GIGANTEUM Seed Extract, have completed their three-year safety monitoring periods. Following evaluation, both were found to comply with the relevant requirements of the Regulations on the Supervision and Administration of Cosmetics and other applicable provisions, and have therefore been included in Part II of the Inventory of Existing Cosmetic Ingredients.



Comments